The Non-Invasive Brain Trauma Monitoring Devices market is projected to grow at a rate of 7.7% in terms of value, from USD 10.19 Billion in 2023 to reach USD 18.35 Billion by 2032.The non-invasive brain trauma monitoring devices (e.g., magnetic resonance imaging (MRI)) is witnessing high demand owing to the growing prevalence of disorders like traumatic brain injury as proper monitoring of conditions necessary to provide treatments such as deep brain stimulation, transcranial direct-current stimulation (tDCS), or transcranial magnetic stimulation (TMS) therapy.
Usually, human brain trauma is twenty torr’s or lower; however, within the presence of a neurological disorder or traumatic head injury, brain tissues can swell. The fluid that encloses and protects the brain may increase in volume, inflicting brain trauma to extend. Hyperbolic brain trauma will cause severe symptoms and, generally, even death. Continuous watching of brain trauma in critical-care patients provides clinicians with the data of whether or not and at what time action should be taken to decrease brain trauma. According to the Center for Disease Control and Prevention (CDC), the leading causes of traumatic brain injury are falls (28%), motor vehicle crashes (20%), being hit by or colliding with an object (19.0%), assaults (11.0%), others (12.0%). Further, CDC reported that from 2006 to 2014, the number of traumatic brain injury-related emergency department visits, hospitalizations, and deaths increased by 53%. In 2014, an average of 155 people in the United States died each day from injuries that include a traumatic brain injury.
Request a Sample@ https://www.qyresearchmedical.com/sample/119195
Intraparenchymal and cavum watching are gold standards of brain trauma activity. However, the procedures needed to live brain trauma with these ways are invasive. They need to gap the bone and carry risks like hurt, infection, and harm to brain tissue. The demand for the minimally invasive procedure is increasing, and these techniques are less traumatic and support the speedy recovery of patients. The non-invasive brain trauma monitoring devices make a major contribution to minimally invasive neurosurgical procedures. The growing acceptance of minimally invasive procedures is likely to impel the demand for these devices. The occurrence of traumatic brain injury is, to a great extent, in the population aged above 40. According to WHO reports between 2015 and 2050, the proportion of the world’s population over 60 years will nearly double from 12.0% to 22.0%. The same also reported that by 2050, the world’s population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015 Thus, the rapidly aging population is projected to be a high impact rendering driver for Non-invasive Brain Trauma Monitoring Devices.
However, a dearth of skilled professionals and a high-cost associated with monitoring devices may create hindrances in the growth of the market in the forecast period
By Type Outlook:
Non-invasive brain trauma monitoring devices contributed to the largest market share in 2019. High brain trauma cases across the globe are the key factor to accelerate the non-invasive brain trauma monitoring devices market growth during the forecast period across all regions. The global magnetic resonance imaging (MRI) market is growing at a substantial pace as the number of spinal & brain diseases and critical injuries in other parts of the body are drastically being propelled globally. An increased awareness about healthcare & wellness, changing neurological & cerebrospinal disease patterns, the government supports, and escalating volumes of implementation of the MRI units in various healthcare centers is expected to upraise the further rapid growth of this market.
The headache disorder application segment was valued at 1.97 billion in 2018 and is expected to grow at the most significant rate of 8.0% in the forecast period. An increasing number of cases of migraine, tension-type headaches is the primary factor contributing to the market growth of this product segment.
As of 2018, Traumatic Brain Injuries is the dominating Non-Invasive Brain Trauma Monitoring Devices application, which holds 26% of the global Non-Invasive Brain Trauma Monitoring Devices market. Asia Pacific market is the chief revenue-generating source for this product segment, followed by North America and Europe regions.
By end-users, hospitals & clinics held the largest market share in 2019 and are projected to witness a growth rate of 7.4% in the forecast period. The factors, including well-resourced diagnostic rooms, higher purchasing power, the existence of highly skilled healthcare professionals, and improved health coverage for hospital-based healthcare services from several private and group insurance plans, among others, are responsible for the high market share of hospitals.
Asia-Pacific regional segment of the Non-Invasive Brain Trauma Monitoring Devices market is expected to remain highest growing segment during 2026-2032, at a CAGR of 8.1%; The developing countries such as India and China are showing significant growth in the healthcare sector and the increasing population and thereby increase in cases of brain trauma will help witness substantial growth in the region.
- The primary research activities are being conducted under the National Institute of Neurological Disorders and Stroke (NINDS) to improve the current state of knowledge on the brain and nervous system and help in the advancement of new technology. The major clinical trials are being conducted to help in the research activities related to brain trauma.
- Other Application segments (that includes Autism, Schizophrenia, Depression, Dementia, Dyslexia) was valued at USD 1.88 billion and is expected to reach over USD 3.50 billion by 2032.
- Europe held around 30.0% of the global Non-Invasive Brain Trauma Monitoring Devices market share in 2019.
- Neurological centers are expected to be the fastest-growing market segment during the forecast period 2026-2032, with a CAGR of 8.3%.
- The market in the North American region is likely to grow at a rate of 7.8% in the forecast period.
Key participants include Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Advanced Brain Monitoring, CAS Medical Systems, Inc., Siemens, Inc., Compumedics Ltd., Medtronic PLC., Integra Lifesciences, among others.
The players operating in the market have undertaken a number of strategies related to the market in the period 2023-2026. Some of the key highlights are:
- In April 2019, Integra Lifesciences, a leading medical technology company introduced the CereLink Intracranial pressure monitor, which helps to capture and share valuable information the doctor needs to manage patients with severe, life-threatening conditions such as traumatic brain injuries.
- In March 2019, GE healthcare launched AIRx, which is an AI-based, automated workflow tool for MRI brain scanning that automatically “prescribes” slices to help reduce redundant, manual steps. It uses deep learning algorithms built right into the MRI technologist’s workflow to automatically identify anatomical structures to prescribe the slice locations, and the angle of those slices, for neurological exams, delivering consistent and quantifiable results.
The industry offers numerous growth opportunities. Thus, a number of startups providing innovative products and technologies have been entering the market. Some of them include Aldans Health, Aural Analytics, Aware, Axosim, Brainmarc, Brainsview, Clarigent Health, and CellExcell, among others.
Mergers and Acquisitions are an integral part of the industry. Along with the companies operating in the market, other key market players have also been entering the industry.
- In October 2019, Neurolign Technologies Inc. made an announcement about the acquisition of Neuro Kinetics Inc., involved in the development of non-invasive neuro-functional and clinical eye-tracking diagnostic testing, providing ground-breaking assessments of neuro-functions.
Reports and Data forecasts promising developments for increased adoption of non-invasive brain trauma monitoring devices. According to industry experts, the use of monitoring devices in headache disorders and Parkinson’s disease is garnering significant traction in the market. New companies entering the industry would emphasize designing and developing innovative products, thereby catering to the increasing requirement of end-users.
Segments covered in the report:
This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the industry trends in each of the sub-segments from 2023 to 2032. The scope of the report can be defined as:
For the purpose of this study, have segmented the non-invasive brain trauma monitoring devices market on the basis of type, application, end-user, and region:
Type Outlook (Revenue, USD Million; 2023-2032)
- Monitoring Devices
- CT scanner
- PET scanner
Application Outlook (Revenue, USD Million; 2023-2032)
- Traumatic Brain Injuries
- Headache disorders
- Other Applications
End-User Outlook (Revenue, USD Million; 2023-2032)
- Neurological Centers
- Diagnostics Labs
- Emergency Care Units
Regional Outlook (Revenue, USD Million; 2023-2032)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Saudi Arabia
- Rest of the Middle East and Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119195/1500
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: